Leaked melanoma vaccine data from Moderna and Merck: doctors cheer, stocks sell off
FROM THE WIRE · FINANCE.YAHOO.COM
Leaked data from Moderna and Merck's highly anticipated melanoma vaccine trial has led to a rare disconnect between doctors, who celebrated the result, and Wall Street, which sold off the stocks.Normally results of such pivotal drug studies are binary, with doctors, patients and…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishThe sell-off suggests the market views the result differently than oncologists do.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Leaked data on the Moderna and Merck melanoma vaccine trial circulated on social media before the presentation.
- 02Oncologists celebrated the result while Wall Street sold the stocks.
- 03The scheduled presentation was at the ESMO meeting in Madrid.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Merck & Co., Inc.145.27 USDMarket closedtoday -1.34%Negative Moderna, Inc.200.10 USDMarket closedtoday -1.25%Negative Moderna Inc49.50 BRLMarket closedtoday -2.75%Negative
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets